CDNA CareDx, Inc.
CareDx, Inc. (CDNA) is expected to report earnings on October 29, 2026, after the market close. The consensus earnings estimate is $0.07 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +6.7% since its last earnings release on July 30, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About CareDx, Inc.
CareDx Inc is a commercial stage company that develops markets and delivers a diagnostic surveillance solution for heart transplant recipients to help clinicians make personalized treatment decisions throughout a transplant patient’s lifetime.
Sector
Healthcare
Industry
Medical Labs & Research